Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-02-19
1996-05-14
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514843, A61K 3156
Patent
active
055167691
ABSTRACT:
Fertilization of an oocyte is inhibited by administering a fertilizing inhibitory amount of an antiprogestin to an ovulatory mammal in an amount which is insufficient to prevent ovulation but sufficient to inhibit fertilization, while the regularity of the menstrual cycle is sustained.
REFERENCES:
patent: 3890356 (1975-06-01), Grunwell et al.
patent: 3928398 (1975-12-01), Grunwell et al.
patent: 4000273 (1976-12-01), Grunwell et al.
patent: 4416822 (1983-11-01), Campbell
patent: 4670426 (1987-06-01), Zor et al.
patent: 5262408 (1993-11-01), Bergink
Batista et al., Delayed Endometrical Maturation Induced by Daily Administration of the Antiprogestin RU 486: A Potential New Contraceptive Strategy, Am J Obstet Gynecol, 167:60, 1992.
Sheth et al., A Randomized, Double-Blind Study of Two Combined and Two Progestogen-Only Oral Contraceptives, Contraception, 25:243, 1982.
Collins et al., Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486, J Clin Endocrinol Metab, 63:1270, 1986.
Danforth et al., Contraceptive Potential of RU 486 By Ovulation Inhibition III Preliminary Observations on Once Weekly Oral Administration, Contraception, 40:195, 1989.
Shoupe et al., Effects of an antiprogenterone RU 486 in normal women II: administration in the late follicular phase, Am J Obstet Gynecol, 157:1421, 1987.
Liu et al., Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone Ru 486, J Clin Endocrinol Metab. 65:1135, 1987.
Luukkainen et al., Inhibition of folliculogenesis and ovaluation by the antigesterone RU 486, Fert Steril, 49:961, 1988.
Messinis et al., The Effect of the Antiprogestin Mifepristone RU-486 On Maturion and In-Vitro Fertilization of Human Oocytes, Br J Obstet Gynecol, 95(6), 1988-Abstract.
Juneja et al., In Vitro Effect of RU 486 On Sperm-Egg Interaction in Mice, Am J Obstet Gynecol, 163:216, 1990.
Chwalisz et al., Inhibition of Estradiol-Mediated Endometrial Gland Formation by the Antigestagen Onapirstone In Rabbits: Relationship to Uterine Estrogen Receptors, Endocrinology 129:312, 1991--Abstract.
Anon., Research Diclosure 28976, 1988.
Hodgen, Surrogate Embryo Transfer Combined with Estrogen-Progesterone Therapy in Monkeys, JAMA 250:2167, 1983.
Chillik et al., Characterizing Pituitary Response to Gonadotropin-releasing Hormone (GnRH) Antagonist in Monkeys: Tonic Follicle-stimualating Hormone/luteinizing Hormone Secretion Versus Acute GnRH Challenge Tests Before, During and After Treatment, Fert. Steril. 48:480, 1987.
Yoshimura et al., Progesterone Protected Oocytes from Premature Degeneration within the Follicle, Nippon Sanka Fujinka Gakkai Zasshi, 42(9):1256, 1990--Abstract.
Sakiz et al. R 2323--An Original Contraceptive Compound, Excerpta Medica, Abs. 86, 1970.
Spitz, Clinical Applications of the Antiprogestin RU 486, The Endocrinologist, 3:58, 1993.
Jordan Kimberly
The Medical College of Hampton Roads
LandOfFree
Method of inhibiting fertilization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting fertilization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting fertilization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895832